Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.6B | $15.1B | $11.8B | $11.6B | $7.6B | |
| Revenue Growth (YoY) | 37.8% | -9.03% | -21.66% | -2.18% | -33.91% | |
| Cost of Revenues | $7.5B | $6.7B | $5.3B | $5B | $3B | |
| Gross Profit | $9.1B | $8.3B | $6.5B | $6.5B | $4.6B | |
| Gross Profit Margin | 54.58% | 55.34% | 54.77% | 56.57% | 60.11% | |
| R&D Expenses | $879.3M | $909.5M | $811.8M | $952.6M | $943.2M | |
| Selling, General & Admin | $3.1B | $3.1B | $2.8B | $2.9B | $2.8B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3B | $3.1B | $2.8B | $2.9B | $2.7B | |
| Operating Income | $6B | $5.3B | $3.7B | $3.7B | $1.9B | |
| Net Interest Expenses | $1.7M | $2.5M | $900.3K | $1.1M | -- | |
| EBT. Incl. Unusual Items | $6.4B | $6B | $4.4B | $4.7B | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9B | $1.8B | $1.2B | $1.3B | $613.2M | |
| Net Income to Company | $6.4B | $6B | $4.4B | $4.7B | $2.4B | |
| Minority Interest in Earnings | $414.9K | $195.8K | $236.1K | $276.6K | $301.7K | |
| Net Income to Common Excl Extra Items | $4.5B | $4.3B | $3.2B | $3.4B | $1.8B | |
| Basic EPS (Cont. Ops) | $3.80 | $3.60 | $2.74 | $2.91 | $1.57 | |
| Diluted EPS (Cont. Ops) | $3.80 | $3.60 | $2.74 | $2.91 | $1.57 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| EBITDA | $6.1B | $5.4B | $3.8B | $3.8B | $2B | |
| EBIT | $6B | $5.3B | $3.7B | $3.7B | $1.9B | |
| Revenue (Reported) | $16.6B | $15.1B | $11.8B | $11.6B | $7.6B | |
| Operating Income (Reported) | $6B | $5.3B | $3.7B | $3.7B | $1.9B | |
| Operating Income (Adjusted) | $6B | $5.3B | $3.7B | $3.7B | $1.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.5B | $2.3B | $1.9B | $3.6B | |
| Revenue Growth (YoY) | -29.31% | -7.78% | -8.31% | -19.98% | 92.84% | |
| Cost of Revenues | $1.1B | $1B | $995.9M | $745.1M | $2.1B | |
| Gross Profit | $1.6B | $1.5B | $1.3B | $1.1B | $1.4B | |
| Gross Profit Margin | 59.63% | 59.23% | 57.01% | 59.81% | 40.46% | |
| R&D Expenses | $216.6M | $199.2M | $207.9M | -- | $295.1M | |
| Selling, General & Admin | $723.5M | $638.1M | $667.3M | $659.8M | $848M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $723.5M | $638.1M | $667.3M | $659.8M | $848M | |
| Operating Income | $910.3M | $858.4M | $653.5M | $449M | $598.4M | |
| Net Interest Expenses | $772.1K | -- | $214.4K | -- | -- | |
| EBT. Incl. Unusual Items | $1B | $1.1B | $873.2M | $225.2M | $950.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $289.5M | $319M | $248.8M | $39.6M | $252.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $109K | $115.7K | -$138.4K | $13.4K | $47.5K | |
| Net Income to Common Excl Extra Items | $718.5M | $805.9M | $624.4M | $185.7M | $697.8M | |
| Basic EPS (Cont. Ops) | $0.61 | $0.69 | $0.54 | $0.16 | $0.60 | |
| Diluted EPS (Cont. Ops) | $0.61 | $0.69 | $0.54 | $0.16 | $0.60 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| EBITDA | $934M | $878.6M | $680.1M | $471.7M | $624.1M | |
| EBIT | $910.3M | $858.4M | $653.5M | $449M | $598.4M | |
| Revenue (Reported) | $2.7B | $2.5B | $2.3B | $1.9B | $3.6B | |
| Operating Income (Reported) | $910.3M | $858.4M | $653.5M | $449M | $598.4M | |
| Operating Income (Adjusted) | $910.3M | $858.4M | $653.5M | $449M | $598.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.1B | $14.2B | $12.5B | $9.3B | $11.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.6B | $6.3B | $5.6B | $4B | $6.4B | |
| Gross Profit | $8.5B | $7.9B | $6.9B | $5.3B | $5.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $888.1M | $885.8M | $851.8M | -- | -- | |
| Selling, General & Admin | $3.2B | $3B | $2.9B | $2.9B | $3.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.2B | $3B | $2.9B | $2.9B | $3.3B | |
| Operating Income | $5.3B | $4.9B | $4.1B | $2.5B | $2B | |
| Net Interest Expenses | $1.3M | $1.2M | $447.1K | $1M | -- | |
| EBT. Incl. Unusual Items | $5.8B | $6.2B | $4.7B | $3B | $3.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7B | $1.8B | $1.3B | $797.3M | $835.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $168.9K | $128.3K | -$121.9K | $685.8K | $291K | |
| Net Income to Common Excl Extra Items | $4.1B | $4.4B | $3.4B | $2.2B | $2.5B | |
| Basic EPS (Cont. Ops) | $3.45 | $3.75 | $2.93 | $1.88 | $2.13 | |
| Diluted EPS (Cont. Ops) | $3.45 | $3.75 | $2.93 | $1.88 | $2.13 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $5.4B | $5B | $4.2B | $2.6B | $2.2B | |
| EBIT | $5.3B | $4.9B | $4.1B | $2.5B | $2B | |
| Revenue (Reported) | $15.1B | $14.2B | $12.5B | $9.3B | $11.7B | |
| Operating Income (Reported) | $5.3B | $4.9B | $4.1B | $2.5B | $2B | |
| Operating Income (Adjusted) | $5.3B | $4.9B | $4.1B | $2.5B | $2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $4.9B | $5.7B | $3.4B | $7.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2B | $2.3B | $1.3B | $4.8B | |
| Gross Profit | $3.4B | $2.9B | $3.4B | $2.1B | $2.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $402.6M | $382.2M | $421.5M | -- | $564.3M | |
| Selling, General & Admin | $1.4B | $1.3B | $1.4B | $1.3B | $1.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.4B | $1.3B | $1.4B | $1.3B | $1.7B | |
| Operating Income | $2B | $1.6B | $2B | $798.8M | $992.4M | |
| Net Interest Expenses | $1.3M | -- | $447.1K | $320.9K | -- | |
| EBT. Incl. Unusual Items | $2.2B | $2.4B | $2.7B | $953.3M | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $617.3M | $687M | $777.9M | $248.1M | $474.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $45K | -$22.9K | -$363.8K | $71.2K | $61.3K | |
| Net Income to Common Excl Extra Items | $1.6B | $1.7B | $1.9B | $705.2M | $1.4B | |
| Basic EPS (Cont. Ops) | $1.32 | $1.48 | $1.67 | $0.61 | $1.17 | |
| Diluted EPS (Cont. Ops) | $1.32 | $1.48 | $1.67 | $0.61 | $1.17 | |
| Weighted Average Basic Share | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | |
| Weighted Average Diluted Share | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | |
| EBITDA | $2.1B | $1.7B | $2.1B | $842.7M | $1B | |
| EBIT | $2B | $1.6B | $2B | $798.8M | $992.4M | |
| Revenue (Reported) | $5.7B | $4.9B | $5.7B | $3.4B | $7.5B | |
| Operating Income (Reported) | $2B | $1.6B | $2B | $798.8M | $992.4M | |
| Operating Income (Adjusted) | $2B | $1.6B | $2B | $798.8M | $992.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.8B | $14.1B | $14.1B | $14.9B | $13.8B | |
| Short Term Investments | $5.1B | $4.1B | $4.6B | $5.1B | $3.2B | |
| Accounts Receivable, Net | $1.3B | $1.2B | $899.4M | $617.9M | $435.5M | |
| Inventory | $785.7M | $1.7B | $1.9B | $1B | $3.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $458.7M | $573.9M | $424.7M | $469.1M | $952.7M | |
| Total Current Assets | $18.3B | $17.5B | $17.4B | $17B | $18.4B | |
| Property Plant And Equipment | $756.3M | $701.7M | $747.7M | $717M | $753.1M | |
| Long-Term Investments | $1.9B | $2.6B | $2.1B | $1.9B | $2.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $135.3M | $141.9M | $139.6M | $108.4M | $156.1M | |
| Other Long-Term Assets | $201.2M | $200.2M | $246.4M | $284.8M | $312.5M | |
| Total Assets | $22.5B | $22.3B | $21.8B | $21.2B | $22.7B | |
| Accounts Payable | $1B | $1.2B | $1.1B | $383.8M | $1.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $2.3B | $1.3B | $1B | $2.1B | $2.4B | |
| Total Current Liabilities | $4.8B | $4.5B | $4B | $3.2B | $4B | |
| Long-Term Debt | $43.8M | $42M | $37.1M | $31M | $36.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.2B | $4.8B | $4B | $4.5B | |
| Common Stock | $91.1M | $82.9M | $75.6M | $66.5M | $67.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $17B | $17B | $17B | $17.2B | $18.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.2M | $2.2M | $1.7M | $8.2M | $7.5M | |
| Total Equity | $17B | $17B | $17B | $17.2B | $18.2B | |
| Total Liabilities and Equity | $22.5B | $22.3B | $21.8B | $21.2B | $22.7B | |
| Cash and Short Terms | $15.8B | $14.1B | $14.1B | $14.9B | $13.8B | |
| Total Debt | $52.2M | $51.4M | $47.2M | $40.5M | $47.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13.2B | $11.4B | $13.9B | $14.1B | $14.3B | |
| Short Term Investments | $3.6B | $3B | $4.4B | $4.8B | -- | |
| Accounts Receivable, Net | $990.7M | $1.1B | $863.5M | $757.9M | $1.2B | |
| Inventory | $2.4B | $2B | $2.1B | $1.8B | $3.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $719.3M | $479.9M | $612.5M | $468.1M | -- | |
| Total Current Assets | $17.3B | $15.1B | $17.5B | $17.2B | $20B | |
| Property Plant And Equipment | $753.2M | $640.6M | $715.1M | $775.9M | $771.9M | |
| Long-Term Investments | $2.2B | $2.4B | -- | $2.3B | $2.6B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.1B | $950.9M | -- | $1.1B | -- | |
| Total Assets | $21.5B | $19.2B | $21.2B | $21.5B | $24.6B | |
| Accounts Payable | $1.8B | $956.1M | $1.1B | $906.5M | $1.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $2.5B | $2B | $2.4B | $2.1B | -- | |
| Total Current Liabilities | $5.1B | $3.8B | $4.3B | $3.3B | $5B | |
| Long-Term Debt | $236.7M | $216.1M | $251.6M | $299.1M | $347.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $4.2B | $4.7B | $3.7B | $5.5B | |
| Common Stock | $90.2M | $69.5M | $67.4M | $70.4M | $68.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.2M | $1.4M | $7.7M | $7.6M | $7.6M | |
| Total Equity | $16B | $15B | $16.5B | $17.8B | $19.1B | |
| Total Liabilities and Equity | $21.5B | $19.2B | $21.2B | $21.5B | $24.6B | |
| Cash and Short Terms | $13.2B | $11.4B | $13.9B | $14.1B | $14.3B | |
| Total Debt | $236.7M | $216.1M | $251.6M | $299.1M | $347.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.4B | $6B | $4.4B | $4.7B | $2.4B | |
| Depreciation & Amoritzation | $101.8M | $93.7M | $81.5M | $123.5M | $100.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$5M | $72.4M | $232.5M | $262.8M | $182.9M | |
| Change in Inventories | $68.3M | -$752.5M | -$337.9M | $856.5M | -$2.2B | |
| Cash From Operations | $5.8B | $2.6B | $2.4B | $3.2B | $79.2M | |
| Capital Expenditures | $66.1M | $67.5M | $163.7M | $111.5M | $124.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3B | $833.8M | $822.8M | -$4.4B | $4.9B | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $2.1B | $1.8B | $1.6B | $1.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $848.5M | $374.4M | -- | -- | |
| Other Financing Activities | -$8M | -$9.8M | -$387.1M | -$5M | -$12.7M | |
| Cash From Financing | -$1.8B | -$3B | -$2.1B | -$1.6B | -$1.3B | |
| Beginning Cash (CF) | $8.4B | $8.4B | $9B | $5.6B | $9.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.9B | $806.6M | $1.3B | -$2.4B | $3.7B | |
| Ending Cash (CF) | $11.6B | $9.6B | $10.5B | $3.7B | $13.1B | |
| Levered Free Cash Flow | $5.7B | $2.5B | $2.2B | $3.1B | -$45.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | $7.8B | $6.9B | $9.4B | $4.4B | $10.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $4.5B | $1.6B | -- | |
| Depreciation & Amoritzation | -- | -- | $78M | $74.4M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -$361.7M | $663.8M | -- | |
| Change in Inventories | -- | -- | -$2.1M | $381.4M | -- | |
| Cash From Operations | $2.7B | $3.7B | $1.3B | $1.9B | -- | |
| Capital Expenditures | -- | $199.3M | $188.8M | $96.9M | $63.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $300.5M | $653M | -$2.1B | -$1.2B | -- | |
| Dividends Paid (Ex Special Dividend) | $808.5M | $2.2B | $1.4B | $1.2B | $34.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $3.9M | $816K | -- | |
| Other Financing Activities | -- | -- | $7.5M | -$1M | -- | |
| Cash From Financing | -$815.4M | -$2.2B | -$1.4B | -$1.2B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.3B | $140.8M | -$1.7B | -$1.3B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.7B | $3.5B | $1.1B | $1.8B | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | $17.8B | $15.2B | $18.6B | $13.7B | $20.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.